Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2012
Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiationBelinda Mei Tze Ling, Narendra Bharathy, Teng-Kai Chung, et al.
ACS Chemical Biology|April 11, 2013
Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitorRahul Modak, Jeelan Basha, Narendra Bharathy, et al.
Biochemical and Biophysical Research Communications|July 12, 2022
Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1Jin-Ah Kim, Noah E Berlow, Melvin Lathara, et al.
The Journal of Pathology|July 26, 2016
P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcomaNarendra Bharathy, Sudha Suriyamurthy, Vinay Kumar Rao, et al.
Oncotarget|October 4, 2017
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcomaNarendra Bharathy, Matthew N Svalina, Teagan P Settelmeyer, et al.
Biochemical and Biophysical Research Communications|May 24, 2023
Structure-activity relationship of dihydropyridines for rhabdomyosarcomaShefali Chauhan, Andrew D Woods, Narendra Bharathy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 14, 2019
Ambient and supplemental magnetic fields promote myogenesis <i>via</i> a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanismJasmine Lye Yee Yap, Yee Kit Tai, Jürg Fröhlich, et al.
Frontiers in Oncology|March 12, 2021
Defining the Extracellular Matrix of RhabdomyosarcomaXiaolei Lian, J Steffan Bond, Narendra Bharathy, et al.
Oncotarget|November 20, 2019
Volasertib preclinical activity in high-risk hepatoblastomaDina Kats, Cora A Ricker, Noah E Berlow, et al.
Pageof 3